RaySearch Laboratories AB (publ)

$206.40+2.99%(+$6.00)
TickerSpark Score
75/100
Solid
57
Valuation
95
Profitability
80
Growth
92
Health
50
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RAY-B.ST research report →

52-Week Range19% of range
Low $166.80
Current $206.40
High $373.50

Companywww.raysearchlabs.com

RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities.

CEO
Johan Lof
IPO
2000
Employees
416
HQ
Stockholm, SE

Price Chart

-34.49% · this period
$365.50$266.95$168.40May 19Nov 14May 22

Valuation

Market Cap
$7.08B
P/E
31.57
P/S
5.43
P/B
6.79
EV/EBITDA
16.50
Div Yield
1.94%

Profitability

Gross Margin
81.36%
Op Margin
21.58%
Net Margin
17.21%
ROE
23.62%
ROIC
14.35%

Growth & Income

Revenue
$1.34B · 12.77%
Net Income
$227.80M · 11.93%
EPS
$6.65 · 11.95%
Op Income
$321.80M
FCF YoY
34.07%

Performance & Tape

52W High
$373.50
52W Low
$166.80
50D MA
$195.76
200D MA
$217.30
Beta
0.93
Avg Volume
161.79K

Get TickerSpark's AI analysis on RAY-B.ST

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our RAY-B.ST Coverage

We haven't published any research on RAY-B.ST yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate RAY-B.ST Report →

Similar Companies